ARKG ETF: ARK Genomic Revolution ETF - Price, Holdings & Analysis
ARK Genomic Revolution ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About ARK Genomic Revolution ETF
What is the current price of ARKG?
The latest ARKG price is $27.36. The 52-week range is $17.50–$34.39. ARKG has returned 34.1% over the past 52 weeks.
What is the expense ratio for ARKG?
ARKG's annual expense ratio is 0.75%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.
Does ARKG pay dividends?
ARK Genomic Revolution ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of ARKG?
ARKG's largest holdings are CRISPR Therapeutics AG (9.2%), Twist Bioscience Corporation (9.2%), Tempus AI, Inc. Class A Common Stock (8.9%) (combined weight: 27.3%). The fund holds 32 total positions. View the complete portfolio breakdown in the Holdings section.
How does ARKG compare to similar ETFs?
Compare ARKG (0.75% expense ratio, $1.11B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.